These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 9375751
1. Non-transferrin-bound iron induced by myeloablative chemotherapy. Bradley SJ, Gosriwitana I, Srichairatanakool S, Hider RC, Porter JB. Br J Haematol; 1997 Nov; 99(2):337-43. PubMed ID: 9375751 [Abstract] [Full Text] [Related]
2. Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy. Harrison P, Marwah SS, Hughes RT, Bareford D. J Clin Pathol; 1994 Apr; 47(4):350-2. PubMed ID: 8027374 [Abstract] [Full Text] [Related]
3. Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications. Belotti A, Duca L, Borin L, Realini S, Renso R, Parma M, Pioltelli P, Pogliani E, Cappellini MD. Leuk Res; 2015 Jan; 39(1):88-91. PubMed ID: 25435028 [Abstract] [Full Text] [Related]
4. Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients. Sahlstedt L, von Bonsdorff L, Ebeling F, Ruutu T, Parkkinen J. Br J Haematol; 2002 Nov; 119(2):547-53. PubMed ID: 12406099 [Abstract] [Full Text] [Related]
5. The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress. Olcay L, Serteser M, Kolay M, Balci HF, Yildirim ÜM, Tekgündüz SA, Hazirolan T, Terzi YK. J Pediatr Hematol Oncol; 2017 Aug; 39(6):425-439. PubMed ID: 28731917 [Abstract] [Full Text] [Related]
6. Non-transferrin-bound iron during allogeneic stem cell transplantation. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Br J Haematol; 2001 Jun; 113(3):836-8. PubMed ID: 11380478 [Abstract] [Full Text] [Related]
7. Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation. Parkkinen J, Sahlstedt L, von Bonsdorff L, Salo H, Ebeling F, Ruutu T. Br J Haematol; 2006 Oct; 135(2):228-34. PubMed ID: 16925790 [Abstract] [Full Text] [Related]
8. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions. Porter JB, Cappellini MD, Kattamis A, Viprakasit V, Musallam KM, Zhu Z, Taher AT. Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462 [Abstract] [Full Text] [Related]
9. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. Sahlstedt L, von Bonsdorff L, Ebeling F, Parkkinen J, Juvonen E, Ruutu T. Eur J Haematol; 2009 Nov; 83(5):455-9. PubMed ID: 19572995 [Abstract] [Full Text] [Related]
10. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry. Jakeman A, Thompson T, McHattie J, Lehotay DC. Clin Biochem; 2001 Feb; 34(1):43-7. PubMed ID: 11239514 [Abstract] [Full Text] [Related]
11. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload. McNamara L, MacPhail AP, Mandishona E, Bloom P, Paterson AC, Rouault TA, Gordeuk VR. J Gastroenterol Hepatol; 1999 Feb; 14(2):126-32. PubMed ID: 10029292 [Abstract] [Full Text] [Related]
12. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GJ, Hoffbrand AV. Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825 [Abstract] [Full Text] [Related]
13. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT). Hilken A, Langebrake C, Wolschke C, Kersten JF, Rohde H, Nielsen P, Kröger N. Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071 [Abstract] [Full Text] [Related]
18. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P. Ann N Y Acad Sci; 2005 Oct; 1054():429-32. PubMed ID: 16339692 [Abstract] [Full Text] [Related]